AZN - יחס חוב להיוון בספרים AstraZeneca AB

AstraZeneca PLC (AZN) relies on manufacturing capacities in the US, Sweden, and the UK to produce oncology drugs. This debt-to-market cap chart illustrates the financial leverage dynamics, where the value 0.66 represents the current magnitude. Growth is driven by M&A deals with biotech firms and the implementation of AI robotics to automate laboratory research and accelerate the discovery of new formulas.

This metric measures financial leverage by comparing total liabilities to the current market value of equity, enabling real-time tracking of the balance between debt load and investment demand. The high margins of the oncology portfolio at AstraZeneca PLC (AZN) minimize debt service risks; therefore, the history of the ratio of financial debt to book capitalization serves as an indicator of the business's resilience to market volatility.